Rick Riemens
Senior scientist at Acerta Pharma B.V. (A member of the AstraZeneca Group) | Ede, Gelderland, Netherlands
Rick Riemens’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Senior scientist at Acerta Pharma B.V. (A member of the AstraZeneca Group) in July 2022 - Present
PhD-student at Vrije Universiteit Amsterdam in July 2018 - June 2022
Research assistent at Vrije Universiteit Amsterdam in September 2017 - June 2018
Vrije Universiteit Amsterdam (VU Amsterdam), Doctor of Philosophy - PhD, August 2026
Vrije Universiteit Amsterdam (VU Amsterdam), Master of Science (MSc), August 2026
HU University of Applied Sciences Utrecht (Hogeschool Utrecht), Bachelor of Applied Science (BASc), August 2026
Acerta Pharma is a European R&D centre of the AstraZeneca group dedicated to the discovery and development of novel innovative drugs for the treatment of haematological malignancies. The company began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced, dedicated team in order to deliver novel targeted therapies for patients with cancer. In 2016 AstraZeneca took a majority stake in the company and Acerta Pharma was fully acquired by AstraZeneca in 2021. We are working to develop new treatment options for patients with specific types of blood cancer. Together with our R&D colleagues of AstraZeneca in Gaithersburg, San Francisco, Boston (US), Gothenburg (SE) and Cambridge (UK) we are committed to innovative drug discovery and development, especially in the field of haematological oncology.
Discover more about Acerta Pharma B.V. (A member of the AstraZeneca Group)Director Medicinal Chemistry at Acerta Pharma / Astrazeneca
Associate Director Medicinal Chemistry at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(August 2022 – Present)
Head of Medicinal Chemistry at Acerta Pharma B.V. (A member of the AstraZeneca Group)
Senior Director Medicinal Chemistry at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(July 2022 – Present)
Global Study Manager at Acerta B.V
Global Study Manager at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(October 2025 – Present)
Strategic Oncology Leader | Driving Portfolio Growth and Commercial Excellence | Board Member
Member of The Supervisory Board at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(May 2022 – Present)
Senior Scientist Medicinal Chemistry @ AstraZeneca | Drug Discovery Pipeline Innovation
Worked on drug discovery program from target validation to candidate nomination
Main responsibilities:
Pipeline Strategy & Decision Making: Lead medicinal chemistry design meetings, driving the critical decision-making process for compound prioritization and Go or No-Go asset ...
Executive Strategy & Business Consultant Life Sciences
RegMed XB ( Regenerative Medicine Crossing Borders) represents a public-private partnership institute of Dutch and Flemish universities, Health Foundations, companies and government bodies focusing on translating regenerative medicine research moving therapies for major chroni...
What is Rick Riemens email address?
Email Rick Riemens at [email protected], [email protected] and [email protected]. This email is the most updated Rick Riemens's email found in 2026.
How to contact Rick Riemens?
To contact Rick Riemens send an email to [email protected], [email protected] or [email protected]. (updated on July 2026)
What company does Rick Riemens work for?
Rick Riemens works for Acerta Pharma B.V. (A member of the AstraZeneca Group).
What is Rick Riemens's role at Acerta Pharma B.V. (A member of the AstraZeneca Group)?
Rick Riemens is Senior scientist
What industry does Rick Riemens work in?
Rick Riemens works in the Research industry.